These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4073803)

  • 21. Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder.
    Atmaca M; Kuloglu M; Tezcan E; Onal S; Ustundag B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):161-5. PubMed ID: 12242576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma and saliva DST (dexamethasone suppression test) in depression. Clinical applications and kinetic approach].
    Piollet I; Lepine JP; Guechot J; Philip E; Rouillon F; Fiet J; Lajeunesse C; Villette JM; Dreux C; Lemperiere T
    Encephale; 1984; 10(6):279-80. PubMed ID: 6529934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dexamethasone suppression test in patients with bulimia.
    Mitchell JE; Pyle RL; Hatsukami D; Boutacoff LI
    J Clin Psychiatry; 1984 Dec; 45(12):508-11. PubMed ID: 6594328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and anxiety inventories, and the dexamethasone suppression test.
    Sangal R; Correa EI; DePaulo JR
    Biol Psychiatry; 1984 Aug; 19(8):1207-13. PubMed ID: 6498243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dexamethasone suppression test and endogenous components of evoked potentials in depressed subjects].
    Pholien P; Charles G; Tilmant JJ; Wilmotte J
    Acta Psychiatr Belg; 1987; 87():694-703. PubMed ID: 3452988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of exercise on adrenocortical responsiveness of patients with chronic low back pain, controlled for psychological strain.
    Chatzitheodorou D; Mavromoustakos S; Milioti S
    Clin Rehabil; 2008 Apr; 22(4):319-28. PubMed ID: 18390975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DST in chronic pain patients not suffering from major depression.
    Magni G; Talamo Rossi R; Stella A; Mottaran R; Salar G
    Pharmacopsychiatry; 1989 Jan; 22(1):8-10. PubMed ID: 2710810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):88-92. PubMed ID: 19054568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
    Appelhof BC; Huyser J; Verweij M; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Tijssen JG; Wiersinga WM; Schene AH
    Biol Psychiatry; 2006 Apr; 59(8):696-701. PubMed ID: 16368077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical complaints correlate better with depression than do dexamethasone suppression test results.
    Silver H
    J Clin Psychiatry; 1986 Apr; 47(4):179-81. PubMed ID: 3957876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants.
    Saran AS
    J Clin Psychiatry; 1985 Aug; 46(8):335-8. PubMed ID: 4019422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA; Greden JF; Tarika J; Carroll BJ
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
    J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment.
    Brown WA; Johnston R; Mayfield D
    Am J Psychiatry; 1979 Apr; 136(4B):543-7. PubMed ID: 426140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated dexamethasone suppression test in major depression.
    Hellebuyck H; Maes M; Suy E
    Acta Psychiatr Belg; 1988; 88(5-6):378-86. PubMed ID: 3079168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortisol responses on the dexamethasone suppression test among women with Bulimia-spectrum eating disorders: associations with clinical symptoms.
    Bruce KR; Steiger H; Israël M; Groleau P; Ng Ying Kin NM; Ouellette AS; Sycz L; Badawi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):241-6. PubMed ID: 22575215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressive symptomatology and dexamethasone suppression test in preschool age children.
    Rosenthal PA; Doherty MB; Rosenthal S
    Hillside J Clin Psychiatry; 1988; 10(1):3-15. PubMed ID: 3410404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.